(Q38123948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

meta-analysis

0 references

title

Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

5

Sharon J Hutchinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

8

Margaret E Hellard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

6

Gregory J Dore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

4

Jason Grebely

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Esther J Aspinall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Stephen Corson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

David J Goldberg

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

57 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

S80-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

Surveillance for newly acquired hepatitis C in Australia

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

What is killing people with hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Hepatitis C treatment for injection drug users: a review of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Should active injecting drug users receive treatment for chronic hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Reinfection with hepatitis C virus following sustained virological response in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Effectiveness of pegylated interferon/ribavirin combination in 'real world' patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT306

21 January 2018

Identifiers

DOI

10.1093/CID/CIT306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884071%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference